Navigation Links
ACR Supports American Cancer Society Inclusion of CT Colonography (Virtual Colonoscopy) as Recommended Screening Tool for Colorectal Cancer in New Screening Guidelines
Date:3/5/2008

PHILADELPHIA, March 5 /PRNewswire-USNewswire/ -- The American College of Radiology concurs with the American Cancer Society (ACS) that the latest published research and preliminary results of recently completed trials support the inclusion of Computed Tomographic Colonography (CTC) -- also known as virtual colonoscopy -- as a front-line screening exam for colorectal cancer.

In the first-ever joint consensus guidelines for colorectal cancer screening, released jointly by the ACS, ACR, and the U.S. Multi-Society Task Force on Colorectal Cancer (a group that comprises representatives from the American College of Gastroenterology, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy), CTC now is included as one of several options for colorectal cancer screening and prevention in average-risk adults age 50 years and older and recommended to be received once every five years.

CT colonography employs cutting-edge, virtual reality technology to produce three-dimensional "fly through" images that permit a thorough and minimally invasive evaluation of the entire colorectal structure. No sedation is required for the exam, allowing patients to resume normal activity, including driving, immediately after the procedure.

Since most colon cancers develop from polyps, and screening to find and remove these polyps can prevent colon cancer, an enormous opportunity exists to save lives with early detection. Yet, despite the known benefits of screening, studies indicate that the majority of Americans aged 50 and older are not being screened for the disease.

"CT colonography, as a minimally invasive exam, can potentially encourage many more people to choose to be screened for colorectal cancer. This could result in early detection of the disease for more patients, increasing the chance of successful treatment, and potentially reduce colorectal cancer deaths nationwide," said Arl Van Moore Jr., M.D., FACR, chair of the ACR Board of Chancellors.

Results of the National CT Colonography Trial coordinated by the American College of Radiology Imaging Network (ACRIN) and presented at the 2007 ACRIN Fall Meeting suggest CTC is comparable to optical colonoscopy for the detection of cancer and clinically significant polyps when state-of-the-art techniques are applied and images are read by radiologists trained in the procedure. Results of the ACRIN trial are expected to be published later this spring.

To ensure acceptable, consistent levels of performance, quality assurance measures should be implemented by all providers who offer this test. The American College of Radiology has published practice guidelines for CTC, and has outlined practice-based quality metrics.

"Radiologists are undergoing the latest training and education to remain at the cutting edge of this technology. The ACR has taken, and continues to take, steps to standardize the performance and interpretation of this exam nationwide, in order to ensure that patients receive the highest quality care," said Moore.

The ACR will open an interactive hands-on training facility for CTC and other cutting-edge imaging procedures. CTC training courses will begin in April 2008. A process for individual certification and proficiency is being evaluated.

"The ACR urges patients to begin being screened for colorectal cancer at age 50 and we strongly urge Medicare and private insurance companies to support screening efforts by reimbursing appropriately for CT colonography," said Moore.

Colorectal cancer is the third most common cancer and second leading cause of cancer death in the United States.

The full ACS guidelines can be viewed at http://caonline.amcancersoc.org/

For further information about the ACRIN National CT Colonography Trial, please visit http://www.acrin.org/TabID/151/Default.aspx.

The American College of Radiology (ACR) is a national professional organization serving more than 32,000 diagnostic radiologists, radiation oncologists, interventional radiologists, nuclear medicine physicians, and medical physicists, with programs focusing on the practice of radiology and the delivery of comprehensive health care services.


'/>"/>
SOURCE American College of Radiology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
2. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
4. Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
5. New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
6. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
7. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
8. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
9. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
10. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
11. New Clinical Data Further Supports Chromium Picolinates Role in Enhancing Brain Activity in Older Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
(Date:10/4/2017)...  According to the Centers for Disease Control and Prevention (CDC), ... Urgent Care is helping communities across Massachusetts , ... offering no-cost* flu shots through the end of the month. ... regulations. ... a flu shot is by the end of October, according to the ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
Breaking Medicine News(10 mins):